Adenosine A2 receptor‐induced inhibition of leukotriene B4 synthesis in whole blood ex vivo
Open Access
- 1 April 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 117 (8) , 1639-1644
- https://doi.org/10.1111/j.1476-5381.1996.tb15334.x
Abstract
1 Engagement of adenosine A2 receptors suppresses several leukocyte functions. In the present study, we examined the effect of adenosine on the inhibition of leukotriene B4 (LTB4) synthesis in heparinized human whole blood, pretreated with lipopolysaccharide (LPS) and tumour necrosis factor α (TNF-α) and stimulated with the chemotactic peptide, N-formyl-Met-Leu-Phe (FMLP). 2 The FMLP-induced synthesis of LTB4 in whole blood pretreated with LPS and TNF-α was dose-dependently inhibited by adenosine analogues in the following order of potency; 5′(N-ethyl)carbox- amidoadenosine (NECA) ≅ CGS 21680 > 2-Cl-adenosine > N6-cyclopentyladenosine (CPA), indicating the involvement of the adenosine A2 receptor subtype. The IC50 values for NECA, CGS 21680, 2-Cl- adenosine, and CPA were 6nM, 9nM, 180nM, and 990 nM, respectively. 3 Dipyridamole, an agent that blocks the cellular uptake of adenosine by red cells and causes its accumulation in plasma, also inhibited the synthesis of LTB4 in LPS and TNF-α-treated whole blood stimulated by FMLP; moreover, this inhibition was reversed upon addition of adenosine deaminase. 4 A highly selective antagonist of the adenosine A2 receptor, 8-(3-chlorostyryl)caffeine (CSC), reversed the inhibition of LTB4 synthesis by 2-Cl-adenosine and dipyridamole in LPS and TNF-α-treated whole blood, stimulated by FMLP. 5 LTB4 synthesis in whole blood originates predominantly from neutrophils and to a lesser extent from monocytes. 2-Cl-adenosine also inhibited the synthesis of LTB4 induced by FMLP in these isolated LPS and TNF-α-treated cells; however, 2-Cl-adenosine was a more potent inhibitor of LTB4 synthesis in neutrophils than monocytes. 6 The present data demonstrate that adenosine, acting through A2 receptors, exerts a potent inhibitory effect on the synthesis of LTB4 and thus contribute to the understanding of its anti-inflammatory properties.Keywords
This publication has 52 references indexed in Scilit:
- Inhibition of human monocyte TNF production by adenosine receptor agonistsLife Sciences, 1993
- Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen.The Journal of Experimental Medicine, 1993
- Adenosine inhibits divalent cation influx across human neutrophil plasma membrane via surface adenosine A2 receptorsCellular Signalling, 1992
- Leukotriene B4 in the immune systemInternational Journal of Immunopharmacology, 1992
- Acute and chronic suppression of leukotriene B4 synthesis EX vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexateArthritis & Rheumatism, 1992
- The role of leukotriene B4 in endotoxin-induced lung injury in unanesthetized sheepRespiration Physiology, 1988
- Leukotriene B4 causes proliferation of interleukin 2-dependent T cells in the presence of suboptimal levels of interleukin 2Cellular Immunology, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Suppression of immunoglobulin production in normal human B lymphocytes by two T-cell subsets distinguished following in vitro treatment with adenosineClinical Immunology and Immunopathology, 1980
- Adenosine Inhibition of Lymphocyte-Mediated Cytolysis: Possible Role of Cyclic Adenosine MonophosphateScience, 1975